Kymera Therapeutics (KYMR) Insider Trading & Ownership

$46.44

-0.86 (-1.82%)

(As of 09/18/2024 ET)

Current Insider Ownership Percentage: 15.82%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $2.52 M
Number Of Insiders Selling (Last 12 Months): 8
Amount Of Insider Selling (Last 12 Months): $40.18 M

Get KYMR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KYMR Insider Buying and Selling by Quarter

Ad Timothy Sykes

Tim Sykes’ Urgent Trade Alert: “Make this move now”

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

Kymera Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/17/2024	Pamela Esposito	Director	Sell	13,500	$48.28	$651,780.00
8/26/2024	Jeffrey W. Albers	Director	Sell	5,000	$49.10	$245,500.00
7/16/2024	Jared Gollob	Insider	Sell	23,145	$45.81	$1,060,272.45
7/9/2024	Bruce Booth	Director	Sell	453,960	$38.21	$17,345,811.60
6/12/2024	Bruce Booth	Director	Sell	16,740	$35.45	$593,433.00
6/7/2024	Joanna Horobin	Director	Sell	8,500	$32.99	$280,415.00
Unlock the Secret to Easy Wins with Iron Condors (Ad) Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consistently without needing a large account or watching the market all day. Our free report, The Top 10 Stocks for Iron Condor Trades, reveals exactly how to set up winning trades with minimal downside. Download Your FREE Iron Condor Guide Now
3/15/2024	Bruce Booth	Director	Sell	71,764	$40.46	$2,903,571.44
3/13/2024	Bruce Booth	Director	Sell	139,255	$42.23	$5,880,738.65
3/13/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	115,090	$42.23	$4,860,250.70
3/11/2024	Bruce Booth	Director	Sell	51,184	$42.85	$2,193,234.40
3/11/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	42,302	$42.85	$1,812,640.70
3/4/2024	Bruce N Jacobs	CFO	Sell	3,934	$41.86	$164,677.24
2/21/2024	Jeffrey W. Albers	Director	Sell	4,385	$39.05	$171,234.25
2/9/2024	Jared Gollob	Insider	Sell	46,137	$35.50	$1,637,863.50
1/23/2024	Jeffrey W. Albers	Director	Sell	10,000	$30.05	$300,500.00
1/4/2024	Ellen Chiniara	Insider	Sell	3,295	$22.58	$74,401.10
11/2/2023	Bvf Partners L P/Il	Director	Buy	216,406	$11.64	$2,518,965.84

(Data available from 1/1/2013 forward)

KYMR Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Kymera Therapeutics includes Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Ellen Chiniara, Jared Gollob, Jeffrey W. Albers, Joanna Horobin, Nello Mainolfi, Pamela Esposito, and Venture Fund X L.P. Atlas. Learn more on insiders at KYMR.
: 15.82% of Kymera Therapeutics stock is owned by insiders. Learn more on KYMR's insider holdings.
: The following insider purchased KYMR shares in the last 24 months: Bvf Partners L P/Il ($3,179,833.74).
: Insiders have purchased a total of 238,516 KYMR shares in the last 24 months for a total of $3,179,833.74 bought.
: The following insiders have sold KYMR shares in the last 24 months: Bruce Booth ($50,893,897.95), Bruce N Jacobs ($207,147.24), Ellen Chiniara ($74,401.10), Jared Gollob ($2,698,135.95), Jeffrey W. Albers ($717,234.25), Joanna Horobin ($280,415.00), Pamela Esposito ($651,780.00), and Venture Fund X L.P. Atlas ($24,492,706.16).
: Insiders have sold a total of 2,303,533 Kymera Therapeutics shares in the last 24 months for a total of $80,015,717.65 sold.